Introduction/Overview
In the broad field of natural product chemistry and pharmacology research, long-chain fatty alcohols, as an important class of bioactive molecules, have long been of concern to researchers. Among them, 1-Octacosanol, as a typical ultra long chain primary fatty alcohol (C28:0), gradually stands out from many plant metabolites due to its unique chemical structure and diverse biological activities, becoming a hot topic in the research of nutritional supplements and potential drug lead compounds. 1-Octacosanol was initially discovered due to its presence in plant sources such as wheat germ oil and sugarcane wax. Early research mainly focused on its efficacy as the main ingredient of docosanol, a cholesterol lowering compound preparation. With the deepening of modern pharmacological research technology, its pharmacological activity spectrum continues to expand, surpassing the traditional lipid-lowering category and demonstrating potential in various aspects such as anti fatigue, anti-inflammatory, cell protection, anti angiogenesis, and even neuroprotection. Especially in the model studies of complex diseases such as inflammatory bowel disease (such as colitis), 1-octacosanol has shown activity in regulating multiple key signaling pathways, suggesting that its mechanism of action involves a complex molecular target network. This article aims to systematically review the chemical properties, plant sources, pharmacological activities, mechanisms of action, medicinal properties, and clinical application prospects of 1-octacosanol, in order to provide comprehensive scientific references for the deep development and utilization of this natural product.
Chemical structure and physicochemical properties
1-Octadecanol, chemical name Octadecan-1-ol, CAS number 557-61-9. Its molecular formula is C28H58O and its molecular weight is 410.7710. Structurally, it is a straight chain aliphatic primary alcohol composed of a saturated hydrocarbon chain containing 28 carbon atoms and a hydroxyl (- OH) functional group located at the end. This ultra long carbon chain structure determines its unique physicochemical properties.
This compound has extremely strong hydrophobicity, with a calculated lipid water partition coefficient (LogP) of up to 12.6459, indicating its high lipophilicity and almost insolubility in water (water solubility is often recorded as 0.0000 mg/mL or very low). Its topological polar surface area (TPSA) is only 20.23 Å ², reflecting the small molecular polarity. These properties result in 1-octacosanol often appearing as a white waxy solid or flaky crystal at room temperature, with a high melting point (approximately 81-83 ° C). The extremely high hydrophobicity also means that its absorption, distribution, metabolism, and excretion (ADME) processes in the organism have special characteristics, usually requiring the use of carriers or special formulations to improve bioavailability. The prediction of pharmacological parameters shows that its ability to penetrate the blood-brain barrier is evaluated as "high", which is consistent with its high lipid solubility and provides a material basis for its potential neurological effects. In addition, preliminary toxicity predictions showed no inhibition of hERG potassium channels (hERG inhibition: No), and the Ames test result was negative (0.0), suggesting that it may not have cardiotoxicity or genotoxicity, and the preliminary safety assessment is good.
Plant sources and extraction methods
1-Octacosanol is widely distributed in nature, but its content is usually low. It mainly exists as an important component of plant epidermal wax and intracellular lipids. Its rich natural sources include:
1. Poaceae plants Wheat germ oil is one of the most famous commercial sources of 1-octacosanol. In addition, sugarcane wax, rice bran wax, and corn wax also contain a considerable proportion.
2. Other plants It has also been detected in many fruits, vegetables, and herbaceous plants such as apple peels, grape skins, spinach, clover, and Moringa.
3. insect wax Beeswax and other insect secretions also contain small amounts.
Due to its coexistence with other long-chain fatty alcohols, fatty acids, alkanes, etc. in the raw materials, separation and purification require multi-step processes. The traditional extraction methods are mainly based on their lipid solubility and crystallization characteristics:
1. Solvent extraction Extract total lipids from dried plant materials or wax using non-polar organic solvents such as n-hexane, petroleum ether, chloroform, etc.
2. Saponification and Separation Saponify the extracted wax under alkaline conditions to break the ester bonds and release the free fatty alcohol mixture.
3. Crystallization and Purification Using the differences in solubility and crystallization temperature of different long-chain fatty alcohols in different solvents (such as acetone and ethanol), separation and purification are carried out through methods such as fractional crystallization and recrystallization. 1-Octacosanol typically precipitates from solvents at higher temperatures due to its longer carbon chain.
4. Modern chromatographic technology To obtain high-purity products, column chromatography (such as silica gel columns), preparative thin-layer chromatography, or high-performance liquid chromatography (HPLC) are often used for final purification.
In recent years, supercritical CO2 extraction technology has also been applied to extract and enrich 1-octacosanol from plant wax due to its advantages of green, high efficiency, and adjustable selectivity, which can better preserve its biological activity.
Pharmacological activity research
A large number of in vitro and in vivo studies have revealed the extensive and diverse pharmacological activities of 1-octacosanol, transforming it from a simple nutritional supplement component to a candidate molecule with multi-target therapeutic potential.
-
Cholesterol lowering and anti atherosclerosis This is the earliest and most extensively studied role of 1-octacosanol. As the core component of docosanol, it can effectively reduce the levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C) in the serum of experimental animals and humans, while possibly increasing high-density lipoprotein cholesterol (HDL-C). Its mechanism of action is different from that of statins. It may play an anti atherosclerotic effect by inhibiting cholesterol synthesis, promoting LDL receptor mediated clearance and affecting lipoprotein metabolism.
-
Anti fatigue and physical fitness enhancement effects Research has shown that 1-octacosanol can significantly prolong the exhaustion swimming or running time of experimental animals, reduce post exercise blood lactate and serum urea nitrogen levels, and increase liver glycogen reserves. Its mechanism may be related to improving energy metabolism (such as enhancing mitochondrial function), reducing oxidative stress damage, and regulating neuroendocrine function, therefore it is widely used in sports nutrition supplements.
-
Anti inflammatory and immune regulatory effects 1-Octacosanol exhibits significant anti-inflammatory activity in various acute and chronic inflammation models. Especially in colitis models, it can effectively reduce colonic tissue edema, erosion, and inflammatory cell infiltration, and lower disease activity index. Its anti-inflammatory effect is closely related to the inhibition of pro-inflammatory factors such as TNF - α, IL-1 β, IL-6.
-
Cell protection and antioxidant effects This compound has a protective effect on various oxidative stress-induced cell damage, such as liver cells, neurons, and endothelial cells. It can enhance the activity of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH Px), eliminate free radicals, and alleviate lipid peroxidation.
-
Antiplatelet aggregation and antithrombotic effects 1-Octacosanol can inhibit platelet aggregation induced by ADP, collagen, etc., affect the arachidonic acid metabolism pathway, and exhibit potential for anti thrombosis.
-
Other activities The study also reported its anti angiogenesis (which may have inhibitory effects on tumor growth and metastasis), neuroprotective (beneficial in models such as Parkinson's disease), and insecticidal biological activities, demonstrating its multifaceted application prospects.
Mechanism of action and molecular targets
The pharmacological effects of 1-octacosanol are not achieved through a single target, but through a complex molecular network. Based on its physicochemical properties, it may regulate signal transduction by directly interacting with membrane proteins or indirectly affecting the lipid raft microenvironment. In response to its outstanding performance in disease models such as colitis, research has revealed several key molecular targets and pathways:
-
Toll like receptor 4/nuclear factor kappa B pathway (TLR4/NF - κ B)TLR4 is a key receptor that recognizes endogenous damage associated molecular patterns (DAMPs) and exogenous pathogen associated molecular patterns (PAMPs), and its overactivation is at the core of driving inflammatory diseases such as colitis. Research has shown that 1-octacosanol can inhibit the expression or activation of TLR4, thereby blocking its downstream signaling. This includes inhibiting the phosphorylation degradation of NF - κ B inhibitory protein (I κ B), preventing the translocation of NF - κ B subunits (such as RELA/p65) into the nucleus, and ultimately downregulating the gene transcription of pro-inflammatory cytokines such as TNF - α, IL-1 β, IL-6.
-
Mitogen activated protein kinase pathway (MAPK)The MAPK family (such as ERK1/2, MAPK1/3, p38, JNK) is an important regulator of inflammation, stress, and cell proliferation. 1-Octacosanol has been shown to inhibit the phosphorylation activation of MAPKs such as ERK1/2 and p38 induced by LPS and other stimuli, thereby synergistically suppressing inflammatory responses.
-
NLRP3 inflammasome pathway The assembly and activation of NLRP3 inflammasomes lead to the cleavage and activation of caspase-1 (CASP1), which in turn promotes the maturation and release of IL-1 β and IL-18, playing a key role in the pathogenesis of colitis. There is evidence suggesting that 1-octacosanol may reduce the activation of caspase-1 and the secretion of IL-1 β by inhibiting the activation of NLRP3 inflammasome.
-
Sphingosine kinase 1/sphingosine-1-phosphate pathway (SPHK1/S1P)SPHK1 catalyzes the generation of S1P, which participates in regulating immune cell migration, vascular permeability, and inflammation through its receptor (such as S1PR1). 1-Octacosanol may affect the inflammatory process by regulating SPHK1 activity or S1P levels.
-
Other potential targets：
- Carboxyesterase 1 (CES1)As a hydrolytic enzyme, it may participate in the metabolic transformation of 1-octacosanol, and its activity changes may also affect the local lipid mediator environment.
- Lysophosphatidic acid receptor 2 (LPAR2)Participating in intestinal barrier function and inflammation regulation may be an indirect target of its action.
- Protein kinase C alpha (PRKCA)Members of the PKC family, involved in various cellular signal transduction, may be regulated by 1-octadecanol.
- Fatty acid amide hydrolase (FAAH)Enzymes that degrade endogenous cannabinoids (such as anandamide), whose activity affects the anti-inflammatory effects of the endocannabinoid system. 1-Octacosanol may indirectly enhance endogenous anti-inflammatory pathways by affecting FAAH.
In summary, 1-octacosanol may synergistically exert anti-inflammatory, antioxidant, and cell protective effects through multi-target and multi pathway pathways, providing a molecular basis for its treatment of complex multifactorial diseases such as colitis.
Evaluation of drug properties and pharmacokinetics
Although 1-Octacosanol has a wide range of biological activities, its extreme hydrophobicity (LogP>12) and almost zero water solubility pose the main challenges in its pharmaceutical process, directly affecting its oral bioavailability.
absorb As a long-chain fatty alcohol, its absorption mechanism may be similar to lipids, mainly absorbed in the small intestine through passive diffusion or formation of mixed micelles with bile acids. The absorption efficiency is low and there are significant individual differences. The intake form (pure product, mixture such as docosanol, or specific formulation) has a significant impact on its absorption.
distribution After absorption, 1-octacosanol may be incorporated into chylomicrons and enter the systemic circulation through the lymphatic system. Its high lipid solubility makes it easy to distribute and accumulate in adipose tissue, liver, muscle, and lipid rich biofilms. It is predicted that it can efficiently penetrate the blood-brain barrier, which provides the possibility for its potential neuropharmaceutical effects.
Metabolism In the body, long-chain fatty alcohols mainly undergo oxidative metabolism. Firstly, it is oxidized to the corresponding long-chain fatty acid (octadecanoic acid) under the action of alcohol dehydrogenase, and then gradually shortens the carbon chain through β - oxidation to generate shorter fatty acids, ultimately entering the conventional fatty acid metabolism pathway (such as the tricarboxylic acid cycle). It may also undergo binding reactions with glucuronic acid or sulfuric acid. Carboxyesterase (CES) may be involved in the hydrolysis of some of its esterification products.
excretion Metabolites are mainly excreted through urine or feces. The possibility of the prototype drug being excreted through the kidneys is extremely low.
Improvement strategy for drug properties In order to improve its bioavailability and efficacy, researchers have adopted various formulation techniques:
1. nano-formulation Prepare nanoemulsions, liposomes, solid lipid nanoparticles, polymer nanoparticles, etc., and encapsulate them in hydrophilic shells to improve water dispersibility and intestinal absorption.
2. Cyclodextrin inclusion complex Using the cavity of cyclodextrin for inclusion to increase its apparent solubility and stability.
3. Self microemulsion drug delivery system Spontaneous formation of microemulsion in the gastrointestinal tract promotes its dissolution and lymphatic absorption.
4. Phospholipid complex Form complexes with phospholipids to improve their lipid solubility and membrane permeability.
These advanced delivery systems have been shown to significantly enhance the oral bioavailability of 1-octacosanol, enhance its pharmacological effects in vivo, and are an important direction for promoting its clinical drug conversion.
Clinical application prospects and prospects
Based on solid preclinical pharmacological evidence and preliminary human safety data (mainly from long-term application experience of docosanol), the clinical application prospects of 1-octacosanol are promising, but also face challenges.
Current Application At present, 1-Octacosanol is mainly sold in the global market in the form of dietary supplements (either as a single ingredient or as the main component of docosanol), used to assist in regulating blood lipids, relieving physical fatigue, enhancing exercise performance, and promoting general health. Docosanol preparations have been approved as natural medicines for mild to moderate hypercholesterolemia in multiple countries.
Future therapeutic potential：
1. Inflammatory bowel disease Given its effective inhibition of key inflammatory pathways such as TLR4/NF - κ B, MAPK, and NLRP3 in colitis models, developing specialized formulations for ulcerative colitis or Crohn's disease is a highly promising direction. Strict randomized controlled clinical trials are needed to verify its efficacy and safety.
2. Diseases related to metabolic syndrome In addition to lowering cholesterol, its regulatory effect on energy metabolism and oxidative stress may improve non-alcoholic fatty liver disease, type 2 diabetes and its complications.
3. Neurological disorders Its high blood-brain barrier penetration, neuroprotective, and anti-inflammatory properties provide a basis for exploring its adjuvant therapeutic effects in ischemic stroke and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
4. Assisted anti-tumor therapy Its anti angiogenic and immune regulatory activities may make it an auxiliary tool for comprehensive treatment of tumors, but further research is needed.
Challenges and Prospects：
1. Bioavailability bottleneck This is the core issue that constrains its efficacy. Future research needs to focus on developing more efficient, stable, and controllable novel drug delivery systems, and conducting systematic pharmacokinetic studies.
2. Deep analysis of the mechanism of action More research is needed to clarify whether it directly acts on specific protein targets or indirectly affects signal transduction by altering cell membrane physical properties or lipid raft composition. It is crucial to use chemical biology methods to search for its direct binding proteins.
3. Upgrading clinical evidence There is an urgent need to design rigorous, large sample, multi center clinical trials to confirm their effectiveness and long-term safety in the treatment of specific diseases, especially colitis, and establish clear dose-response relationships.
4. Structural optimization and derivative development Using it as the parent nucleus, improving its water solubility and pharmacokinetic properties through chemical modifications (such as introducing polar groups and preparing prodrugs) may result in derivatives with better activity and drug properties.
Conclusion
1-Octacosanol, as a naturally occurring long-chain fatty alcohol, has shown broad prospects in pharmacology from nutritional supplementation to disease treatment due to its unique chemical structure and multi-target action characteristics. From its initial lipid-lowering activity, its biological effects in anti-inflammatory, antioxidant, anti fatigue, neuroprotective and other aspects have gradually been revealed, especially its protective effect in colitis models by regulating key signaling pathways such as TLR4/NF - κ B and MAPK, highlighting its value as an anti-inflammatory lead compound. However, the low bioavailability caused by its extreme hydrophobicity is the main obstacle on its path from an "active molecule" to an "effective drug". In the future, through interdisciplinary collaboration, combined with modern formulation technology, molecular pharmacology, and clinical medicine, we will further elucidate its precise mechanism of action, optimize its administration strategy, and conduct high-quality clinical research, which is expected to fully unleash the therapeutic potential of 1-octacosanol and provide a new, multi-functional, and safe natural source treatment option for metabolic diseases, inflammatory diseases, and other conditions.
